Therapeutic Drug Monitoring

Sampling time determines how a measured concentration relates to the patient’s exposure. A result collected at an inappropriate point may not be comparable with the intended therapeutic range, even when the assay itself is valid. Clinicians therefore interpret the concentration alongside the dose and collection time, allowing pharmacokinetic analysis to support a defensible dosing decision.

Organ function, drug interactions, dose, and adherence can all alter the concentration observed in a biological sample. These variables help explain why two patients receiving the same regimen may show different exposure. Considering them during pharmacokinetic interpretation prevents clinicians from treating an isolated measurement as sufficient evidence and supports a more individualized adjustment when exposure is excessive or inadequate.

Therapeutic drug monitoring provides the greatest benefit when small concentration changes may separate effective treatment from toxicity, or when drug disposition varies substantially among patients. In these circumstances, a measured value can add information that dose alone cannot provide. The result becomes clinically meaningful when combined with the patient’s status and the intended exposure target.

A practical workflow begins by documenting the regimen and obtaining a timed biological sample. The sample is analyzed with a validated assay, after which the measured concentration is considered with dose history, organ function, interactions, and adherence. Pharmacokinetic interpretation then links the result to a target range, while clinical assessment determines whether a regimen change is appropriate.

An above-target concentration may prompt concern about toxicity, whereas a below-target result may indicate inadequate exposure; neither conclusion should rely on the number alone. Clinicians integrate the result with treatment response, safety findings, and factors such as organ function or interactions. This combined assessment helps determine whether a regimen adjustment is warranted.

In clinical care, the approach supports precision dosing by linking laboratory measurements with pharmacokinetic reasoning and patient assessment. In pharmacology research, it can make treatment outcomes more reliable by documenting actual exposure rather than relying only on prescribed dose. Its value lies in connecting measured concentrations to effectiveness and safety, particularly when exposure differs across patients.